miR-190-5p Alleviates Myocardial Ischemia-Reperfusion Injury by Targeting PHLPP1
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-190-5p Alleviates Myocardial Ischemia-Reperfusion Injury by Targeting PHLPP1
Authors
Keywords
-
Journal
DISEASE MARKERS
Volume 2021, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2021-11-26
DOI
10.1155/2021/8709298
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of PHLPP1 ameliorates cardiac dysfunction via activation of the PI3K/Akt/mTOR signalling pathway in diabetic cardiomyopathy
- (2020) Mingjun Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Luteolin attenuates doxorubicin-induced cardiotoxicity by modulating the PHLPP1/AKT/Bcl-2 signalling pathway
- (2020) YanDong Zhang et al. PeerJ
- MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model
- (2019) Qiang Sun et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Enhanced Neutrophil Immune Homeostasis Due to Deletion of PHLPP
- (2019) Taojing Ran et al. Frontiers in Immunology
- miR-190-5p in human diseases
- (2019) Yue Yu et al. Cancer Cell International
- MicroRNA-374 Exerts Protective Effects by Inhibiting SP1 Through Activating the PI3K/Akt Pathway in Rat Models of Myocardial Ischemia-Reperfusion After Sevoflurane Preconditioning
- (2018) Shu-Bo Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection
- (2018) Susana Cadenas FREE RADICAL BIOLOGY AND MEDICINE
- The protective role of curcumin in myocardial ischemia-reperfusion injury
- (2018) Amin Mokhtari-Zaer et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Tumor necrosis factor-alpha upregulated PHLPP1 through activating nuclear factor-kappa B during myocardial ischemia/reperfusion
- (2018) Bin Tang et al. LIFE SCIENCES
- Effects of endogenous cardioprotective mechanisms on ischemia-reperfusion injury
- (2017) Marcin Kunecki et al. Postepy Higieny I Medycyny Doswiadczalnej
- Apelin/APJ System: A Novel Therapeutic Target for Myocardial Ischemia/Reperfusion Injury
- (2016) Zhe Chen et al. DNA AND CELL BIOLOGY
- Renal microRNA- and RNA-profiles in progressive chronic kidney disease
- (2016) Michael Rudnicki et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Toward the promise of microRNAs – Enhancing reproducibility and rigor in microRNA research
- (2016) Kenneth W. Witwer et al. RNA Biology
- PHLPP negatively regulates cell motility through inhibition of Akt activity and integrin expression in pancreatic cancer cells
- (2016) Alena J. Smith et al. Oncotarget
- Deletion of the PH-domain and Leucine-rich Repeat Protein Phosphatase 1 (Phlpp1) Increases Fibroblast Growth Factor (Fgf) 18 Expression and Promotes Chondrocyte Proliferation
- (2015) Elizabeth W. Bradley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Akt activation by PHLPP1 ablation prevents pathological hypertrophy by promoting angiogenesis
- (2014) Mingchuan Li et al. CARDIOVASCULAR RESEARCH
- A review of melatonin as a suitable antioxidant against myocardial ischemia-reperfusion injury and clinical heart diseases
- (2014) Yang Yang et al. JOURNAL OF PINEAL RESEARCH
- Myocardial ischemia-reperfusion injury: a neglected therapeutic target
- (2013) Derek J. Hausenloy et al. JOURNAL OF CLINICAL INVESTIGATION
- PHLiPPing the switch on Akt and protein kinase C signaling
- (2008) John Brognard et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now